The Scientia deal follows Medtronic’s announcement in February that it’ll acquire CathWorks for up to $585 million.

The peripheral vascular device market will rise from $10.4B in 2025 to $14.8B by 2032, driven by drug‑coated balloons, ...

Medtronic has bought a stroke-treating device firm for $550 million as the Fridley-operated medtech company executes its growth strategy of mergers and acquisitions. Scientia Vascular launched the ...

BEYONDmLM.com campaign designed to educate, engage, and empower patients, caregivers, and healthcare professionals Campaign developed and launched in close collaboration with leading nonprofit ...

Daily intake of avocado and mango may improve endothelial function in people with prediabetes, according to new data ...

Vascular Health Improvement: Due to changing lifestyles, diseases that used to affect us after 40 or 50 years of age are now affecting young people between 20 and 30 years of age. Let us tell you ...

Boston Scientific (NYSE:BSX) announced today that it promoted Catherine Jennings to become its new president of Vascular ...

A new clinical trial has found that a multi-ingredient longevity supplement may help improve key markers of vascular aging, ...

A meta-analysis shows GLP-1 RA therapy does not significantly lower vascular dementia events compared with placebo in high-risk patient groups.

LeMaitre Vascular maintains a robust $190M net cash position and recently increased its dividend by 25%. Click here to find ...

Vascular surgery can treat conditions that affect the blood vessels in your body. It may be recommended when vascular disease is advanced or increases your risk of serious health outcomes. There are ...